Ocular Therapeutix Inc. buy Chardan Capital
Start price
02.10.25
/
50%
€9.43
Target price
02.10.26
€17.89
Performance (%)
-17.65%
Price
06.02.26
€7.76
Summary
This prediction is currently active. The prediction for Ocular Therapeutix Inc. disappoints with a performance of -17.65%. This prediction currently runs until 02.10.26. The prediction end date can be changed by Chardan_Capital at any time. Chardan_Capital has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Ocular Therapeutix Inc. | 0.727% | 0.727% |
| iShares Core DAX® | 1.085% | -1.655% |
| iShares Nasdaq 100 | -1.665% | -3.137% |
| iShares Nikkei 225® | 3.863% | 6.947% |
| iShares S&P 500 | 0.111% | -1.320% |
Comments by Chardan_Capital for this prediction
In the thread Ocular Therapeutix Inc. diskutieren
Ocular Therapeutix (NASDAQ:OCUL) had its "buy" rating reaffirmed by analysts at Chardan Capital. They now have a $21.00 price target on the stock.
Ratings data for OCUL provided by MarketBeat
Stopped prediction by Chardan_Capital for Ocular Therapeutix Inc.
Ocular Therapeutix Inc.
Start price
Target price
Perf. (%)
€13.61
09.12.25
09.12.25
€18.03
09.12.26
09.12.26
-42.97%
06.02.26
06.02.26
Ocular Therapeutix Inc.
Start price
Target price
Perf. (%)
€9.36
05.11.25
05.11.25
€18.27
05.11.26
05.11.26
-17.07%
06.02.26
06.02.26
Ocular Therapeutix Inc.
Start price
Target price
Perf. (%)
€10.62
15.09.25
15.09.25
€17.90
15.09.26
15.09.26
-26.88%
06.02.26
06.02.26